Taienkang (301263.SZ): Application for registration and marketing license for the domestic production of methimazole tablets was accepted

Zhitong Finance App News, Taienkang (301263.SZ) announced that Shandong Huabo Kaisheng Biotechnology Co., Ltd. (“Huabo Kaisheng”), a wholly-owned subsidiary of the company, recently received the “Notice of Acceptance” of the application for registration and marketing of drugs produced domestically by methimazole tablets issued by the State Drug Administration. According to the announcement, methimazole is an imidazole antithyroid drug. By inhibiting the activity of thyroid peroxidase (TPO), a key enzyme in the thyroid gland, it blocks the absorption of the coupling of iodide and tyrosine in the thyroid gland, and hinders the synthesis of thyroid T4 and triiodothyronine T3. A

Zhitong FinanceApr 26 21:41

Express News | Tai Enkang: Director Li Ting plans to increase the company's shares by 2 million yuan to 4 million yuan

BreakingsApr 23 19:16

Express News | Tai Enkang: Mr. Li Ting plans to increase his holdings by no less than RMB 2 million and no more than RMB 4 million

BreakingsApr 23 18:35

Taienkang (301263.SZ) announced its 2023 annual results, with net profit of 160 million yuan, a decrease of 8.26%

Taienkang (301263.SZ) released its 2023 annual report. The company's revenue was 761 million yuan,...

Zhitong FinanceApr 22 20:48

Express News | Taienkang: The wholly-owned subsidiary received a notice of acceptance of alendronate sodium tablets

BreakingsApr 18 19:56

Taienkang (301263.SZ): Application for marketing license for topical hair loss treatment “minoxidil liniment” accepted

Taienkang (301263.SZ) announced that Shandong Huabo Kaisheng Biotechnology Co., Ltd., a wholly-owned subsidiary of the company, recently...

Zhitong FinanceApr 1 16:13